Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Allogene Therapeutics, Inc. | ALLO | 13.32M | $27.71M |
Protara Therapeutics, Inc. | TARA | 1.92M | $7.34M |
Aquestive Therapeutics, Inc. | AQST | 1.49M | $6.18M |
Vir Biotechnology, Inc. | VIR | 1.08M | $10.96M |
Relmada Therapeutics, Inc. | RLMD | 1M | $6.94M |
Viatris Inc. | VTRS | 954.3K | $15.15M |
Waystar Holding Corp. | WAY | 925.83K | $19.01M |
Maximus, Inc. | MMS | 715.27K | $38.45M |
Tyra Biosciences, Inc. | TYRA | 695.32K | $22.21M |
EyePoint Pharmaceuticals, Inc. | EYPT | 623.13K | $8.91M |
Ocular Therapeutix, Inc. | OCUL | 539.49K | $5.3M |
IDEAYA Biosciences, Inc. | IDYA | 480.38K | $17.9M |
GSK plc | GSK | 436.7K | $22.89M |
Aveanna Healthcare Holdings Inc. | AVAH | 369.04K | $3.16M |
Sanofi | SNY | 364.2K | $15.54M |
Rapport Therapeutics, Inc. Common Stock | RAPP | 307.66K | $12.82M |
Globus Medical, Inc. | GMED | 301.82K | $23.85M |
Zenas BioPharma, Inc. | ZBIO | 208.56K | $5.29M |
Tango Therapeutics, Inc. | TNGX | 208.5K | $6.52M |
Bristol-Myers Squibb Company | BMY | 193.5K | $11.15M |